Buck Institute For Age Research operates a non-profit scientific research institute. Its facility focuses on understanding the connection between aging and chronic diseases. The company also develops regenerative medicine and aging programs. Buck Institute For Age Research was founded in 1985 and is based in Novato, California.
8001 Redwood Boulevard
Novato, CA 94945
Founded in 1985
Mount Tam Biotechnologies Signs on License Agreement with Buck Institute for Age Research
Aug 22 14
Mount Tam Biotechnologies has entered into a worldwide licensing and collaboration agreement with the Buck Institute for Age Research. The agreement includes the Institute's advanced research and development assets in the area of autoimmune disorders. The license contains TAM-01, a pre-IND stage compound, which represents a therapeutic for the treatment of systemic lupus erythematosus (SLE) the common form of lupus. In addition, the agreement also includes other, earlier stage compounds and an extensive library of assets positioned in the autoimmune disease space.
Ultragenyx Pharmaceutical Inc. Executes Amendment No. 2 to License and Services Agreement with the Buck Institute for Research on Aging
Aug 21 14
Ultragenyx Pharmaceutical Inc. executed Amendment No. 2 to License and Services Agreement, which amends that certain License and Services Agreement, dated as of September 24, 2010, between the company and The Buck Institute for Research on Aging (Buck), which was previously amended by that certain Amendment No. 1 to License and Services Agreement, dated as of September 4, 2012 (as so amended, the Agreement). The amendment is deemed effective as of September 15, 2014 and amends the agreement by providing the company with certain additional laboratory and office space, increasing the annual and monthly rent to $305,000.00 and $25,416.67, respectively, and giving the company a right of first refusal to license additional space, at a fee of $73,872 per year, during the term of the amendment. Additionally, the amendment extends the term of the agreement to continue through September 15, 2019, which term may be extended by an additional twelve months for up to three consecutive years. The amendment also grants the company an exclusive license to use certain equipment.
Chester Aldridge Joins Buck Advisory Council
Dec 19 13
Chester Aldridge, Chairman and CEO of US Equity Holdings, has joined the Buck Institute's Buck Advisory Council (BAC). The long-time Marin resident will take an active role in advising the Institute on the commercialization of some of its most promising research assets. At US Equity Holdings, Aldridge has established, financed and managed multiple ventures in the fields of entertainment, biotechnology, and renewable energy. Over the last several months, Aldridge and the US Equity Holdings team have accelerated their licensing deals and are quickly moving toward the establishment of a strategy that leads to the commercialization of some key assets and discoveries from the Buck Institute, under a new venture known as Project Golden State.